These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 4145461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L, Fefer A.
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells.
    Fefer A.
    Cancer Res; 1973 Apr; 33(4):641-4. PubMed ID: 4696464
    [No Abstract] [Full Text] [Related]

  • 4. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA.
    Exp Hematol; 1973 Apr; 1(3):135-49. PubMed ID: 4153858
    [No Abstract] [Full Text] [Related]

  • 5. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ, Esparza AR, Albala MM.
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [Abstract] [Full Text] [Related]

  • 6. Heterogenization of normal tissues in oncogenesis. A skeptical review.
    Mariani T, Good RA.
    Isr J Med Sci; 1973 Mar; 9(3):380-94. PubMed ID: 4575655
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M, Keys LD, Gaston M, Goldin A.
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy.
    Chester SJ, Esparza AR, Albala MM.
    Cancer Res; 1975 Mar; 35(3):634-6. PubMed ID: 234788
    [Abstract] [Full Text] [Related]

  • 12. Studies of adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L, Fefer A.
    Cancer Res; 1972 May; 32(5):997-1001. PubMed ID: 5061637
    [No Abstract] [Full Text] [Related]

  • 13. Immunotherapy in leukemia. Experimental and clinical approaches.
    Mathé G.
    Ser Haematol; 1972 May; 5(5):66-86. PubMed ID: 4151467
    [No Abstract] [Full Text] [Related]

  • 14. Adoptive immunotherapy of disseminated malignancies. Role of alien histocompatibility antigens on cancer cells and effectiveness of cells from alloimmunized donors.
    Tempelis LD, Wasik MR, Bortin MM.
    Ric Clin Lab; 1983 May; 13(2):163-82. PubMed ID: 6604934
    [Abstract] [Full Text] [Related]

  • 15. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
    Bortin MM, Rimm AA, Rodey GE, Giller R, Saltzstein EC.
    Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270
    [No Abstract] [Full Text] [Related]

  • 16. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors.
    Glynn JP, McCoy JL, Fefer A.
    Cancer Res; 1968 Mar; 28(3):434-9. PubMed ID: 4867923
    [No Abstract] [Full Text] [Related]

  • 17. Immunocompetent cell functions in mice infected with Friend leukemia virus.
    Bennett M, Steeves RA.
    J Natl Cancer Inst; 1970 May; 44(5):1107-19. PubMed ID: 4398242
    [No Abstract] [Full Text] [Related]

  • 18. Immunology of virus-induced tumours.
    Sjögren HO.
    Mod Trends Med Virol; 1967 May; 1(0):207-22. PubMed ID: 4366129
    [No Abstract] [Full Text] [Related]

  • 19. Editorial: Prophylactic immunotherapy.
    Med J Aust; 1975 Aug 30; 2(9):332-3. PubMed ID: 241897
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.